A nomogram for survival was constructed and validated in patients treated with chemotherapy for advanced BTC using data derived from two randomized trials. The nomogram included lymph node metastasis, liver metastasis, CA19-9, CEA, albumin, and CRP, and its external validity was not problematic in the test set. This evidence concerns the gene CRP and metastatic malignant neoplasm in the lymph nodes.